Table 3.
Treatments during hospitalization of 1077 patients between AKI and non-AKI group.
| Variables | Non-AKI (n=1017) | AKI (n=60) | Total (n=1077) | P-value | Missing |
|---|---|---|---|---|---|
| Antiviral | 953/1015 (93.9%) | 58/60 (96.7%) | 1011/1075 (94.0%) | 0.547 | 2 |
| Antibiotic | 714/1015 (70.3%) | 54/60 (90.0%) | 768/1075 (71.4%) | 0.001 | 2 |
| Glucocorticoids | 256/1014 (25.2%) | 32/59 (54.2%) | 288/1073 (26.8%) | <0.001 | 4 |
| Gamma globulin | 148/1014 (14.6%) | 28/59 (47.5%) | 176/1073 (16.4%) | <0.001 | 4 |
| Traditional Chinese medicine | 903/1015 (89.0%) | 41/59 (69.5%) | 944/1074 (87.9%) | <0.001 | 3 |
| RRT | 9/1015 (0.9%) | 11/60 (18.3%) | 20/1075 (1.9%) | <0.001 | 2 |
| High flow nasal catheter oxygen inhalation |
239/1014 (23.6%) | 27/60 (45%) | 266/1074 (24.8%) | <0.001 | 3 |
| Non-invasive ventilation | 83/1013 (8.2%) | 26/60 (43.3%) | 109/1073 (10.2%) | <0.001 | 4 |
| Invasive mechanical ventilation | 42/1014 (4.1%) | 26/60 (43.3%) | 68/1074 (6.3%) | <0.001 | 3 |
| ECMO | 3/1014 (0.3%) | 3/60 (5.0%) | 6/1074 (0.6%) | 0.003 | 3 |
| Convalescent plasma | 7/1013 (0.7%) | 0/60 (0%) | 7/1073 (0.7%) | >0.999 | 4 |
RRT, renal replacement therapy; EMCO, Extracorporeal membrane oxidation.